Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Zarbá, Jj"'
Autor:
Lee, Ay, Kamphuisen, Pw, Meyer, G, Bauersachs, R, Janas, Ms, Jarner, Mf, Khorana, Aa, Bella, Sr, Cerana, S, Zarbá, Jj, Johannes, A, Barrios, Ch, Borba, Ra, Cesario, F, de Azevedo, S, Ferreira Filho, Af, Franke, Fa, Padilha, S, Paiva, Qr, Pimenta, A, Rerin, J, Rigo, R, Rocha Van Eyll, Sb, Santos, Bg, Vacaro, G, Anastasov, V, Dragneva, T, Georgiev, G, Champion, P, Kuruvilla, P, Gonzalez, C, Ditl, P, Förster, J, Lubomir, B, Vydra, J, Abo El Hassan, R, Sabri, S, Allahloubi, N, Elzawawy, A, Ezzat, Ss, Sabry el, Km, Bacchus, L, Beyer Westendorf, J, Kamphausen, U, Niederwieser, D, Ostermann, H, Sosada, M, Anagnostopoulos, N, Fountzilas, G, Ioannou, C, Liapis, C, Barrios, Sf, Atilli, S, Balsubramanian, S, Bondarde, S, Desai, Sc, Deshmukh, C, Singh, Dp, Gharami, F, Goyal, L, Gupta, S, Gupte, S, Mukherjee, Kk, Krishnan, S, Kumar, K, Mehta, A, Mishra, K, Naik, R, Pawar, S, Rajnish, Vn, Warrier, N, Brenner, B, Gavish, I, Lugassy, G, Kolin, M, Enrico, B, Mazzucconi, Maria Gabriella, Visani, G, Awidi, A, Novikovs, N, Miscuks, J, Abigerges, D, Farhat, F, Khoueiry, P, Makarem, J, Alvarez Ordorica, O, Anaya Santacruz, E, Calderillo Ruiz, G, De la Concha Ureta, Hj, Pantigoso Wuilbert, Sr, Philco, M, Romero Pineda, A, Vargas Queszada, Ea, Gawrychowski, K, Witkiewicz, W, Macias, E, Teixeira, E, Ciuleanu, Te, Ligia, Cc, Lungulescu, D, Manolescu, Ig, Rodica, A, Volovat, C, Burov, Y, Katelnitsky, I, Svistov, D, Ahmad, K, Algahtani, F, Al Zahrani, H, Qari, M, Jovanovic, D, Milanovic, N, Perin, B, Stojanovic, V, Tomasic, L, Chovanec, J, Herman, O, Kissova, V, Sasvary, F, Špánik, S, Szentivanyi, M, Barón, F, Gallardo, E, Jiménez, D, Remedios, O, Sanchez, A, Engelbrecht, J, Jonas, N, Mcadam, G, Patel, M, Rapoport, B, Robertson, B, Oh, D, Kim, H, Kim, Hk, Kim, Hj, Kim, Hs, Ahn, Js, Chung, J, Jang, J, Park, Ku, Shin, Sw, Kim, Sh, Yoon, Ss, Kim, Yk, Chiu, Cf, Chang, Cs, Liu, Jh, Rau, Km, Chen, Sw, Chittima, S, Ekkapong, T, Nonglak, K, Pantep, A, Pramook, M, Thanakrit, S, Patrapim, S, Sumitra, T, Udomluck, C, Kobza, I, Nykonenko, O, Prasol, V, Vladychuk, I.
Publikováno v:
JAMA-Journal of the American Medical Association, 314(7), 677-686. AMER MEDICAL ASSOC
Importance Low-molecular-weight heparin is recommended over warfarin for the treatment of acute venous thromboembolism (VTE) in patients with active cancer largely based on results of a single, large trial. Objective To study the efficacy and safety
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sternberg CN; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Davis ID; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Mardiak J; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Szczylik C; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Lee E; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Wagstaff J; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Barrios CH; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Salman P; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Gladkov OA; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Kavina A; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Zarbá JJ; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Chen M; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., McCann L; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Pandite L; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Roychowdhury DF; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC., Hawkins RE; From the Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy; Ludwig Oncology Unit, Austin Hospital, Melbourne, Australia; National Oncological Institute, Klenová, Bratislava, Slovakia; Department of Oncology, Military Institute of Medicine, Warsaw, Poland; Department of Urology, Seoul National University College of Medicine, Seoul, Korea; The South West Wales Cancer Institute, Singleton Hospital, Swansea; Cancer Research UK, Department of Medical Oncology, University of Manchester; Christie Hospital National Health Services Foundation Trust, Manchester, United Kingdom; Oncology Research Unit, Oncology Service, Hospital Sao Lucas, Pontifícia Universidade Católica do Rio Grande do Sol, Porto Alegre, Brazil; Division of Medical Oncology and Hematology, Fundación Arturo López Pérez, Santiago, Chile; Chelyabinsk Regional Oncology Center, Chelyabinsk, Russian Federation; Krankenhaus Heitzing, mit Neurologischem Zentrum Rosenhugel, Vienna, Austria; Centro Médico San Roque, Tucumán, Argentina; GlaxoSmithKline, Collegeville, PA; and GlaxoSmithKline, Research Triangle Park, NC.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Apr 10; Vol. 41 (11), pp. 1957-1964.
Autor:
Zarbá M; FUCA, Instituto Alexander Fleming, CABA C1426ANZ, Argentina.; https://orcid.org/0000-0003-3642-4035., Angel M; Genitourinary Tumors Department, Instituto Alexander Fleming, CABA C1426ANZ, Argentina.; These authors have contributed equally to this work.; https://orcid.org/0000-0002-1463-8887., Losco F; Genitourinary Tumors Department, Instituto Alexander Fleming, CABA C1426ANZ, Argentina.; https://orcid.org/0000-0001-5084-3012., Zarbá JJ; Oncology Department, Hospital Zenon Santillan, San Miguel de Tucuman T4000IAK, Argentina.; https://orcid.org/0000-0003-1013-3993., Pupilli JC; Genitourinary Tumors Department, Sanatorio Británico Rosario, Santa Fé S2000ANZ, Argentina., Chacon MR; Oncology Department, Instituto Alexander Fleming, CABA C1426ANZ, Argentina.; https://orcid.org/0000-0001-6872-4185., Sade JP; Genitourinary Tumors Department, Instituto Alexander Fleming, CABA C1426ANZ, Argentina.; https://orcid.org/0000-0001-9312-5280.
Publikováno v:
Ecancermedicalscience [Ecancermedicalscience] 2022 Dec 02; Vol. 16, pp. 1480. Date of Electronic Publication: 2022 Dec 02 (Print Publication: 2022).
Autor:
Maluf FC; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Beneficência Portuguesa de São Paulo, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Pereira FMT; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Silva AG; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Oncologia Clínica ICTr, Curitiba, Brazil., Dettino ALA; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital AC Camargo, São Paulo, Brazil., Cardoso APG; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Sasse AS; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Grupo Sonhe, Campinas, Brazil., Soares A; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Centro Paulista de Oncologia, Oncoclínicas, São Paulo, Brazil., Kann AG; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil., Herchenhorn D; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Grupo de oncologia D'Or, Rio de Janeiro, Brazil.; Instituto D'Or de ensino e pesquisa, Rio de Janeiro, Brazil., Jardim DLF; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital Sírio Libanês, São Paulo, Brazil., Cortés DEL; Clínica Oncólogos del Occidente SAS, Manizales, Colombia., Kater FR; Beneficência Portuguesa de São Paulo, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Morbeck IAP; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital Sírio Libanês, Brasília, Brazil.; Universidade Católica de Brasília, Brasília, Brazil., Reolon JFN; Beneficência Portuguesa de São Paulo, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Rinck JA Jr; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital AC Camargo, São Paulo, Brazil., Zarbá JJ; Hospital Zenon Santillán, Nacional University of Tucumán, Tucumán, Argentina., Sade JP; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Instituto Alexander Fleming y de la Universidad Austral, Buenos Aires, Argentina., da Trindade KM; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; IEP-Instituto de Ensino e Pesquisa Oncocentro, Fortaleza, Brazil., Costa LAGA; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Grupo de oncologia D'Or, Rio de Janeiro, Brazil., Dos Santos LV; Beneficência Portuguesa de São Paulo, São Paulo, Brazil., Maia MC; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Centro de Oncologia do Paraná, Curitiba, Brazil., Siqueira MB; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Grupo de oncologia D'Or, Rio de Janeiro, Brazil., Gillessen S; Oncology Institute of Southern Switzerland (IOSI), Bellinzona and Università della Svizzera Italiana, Lugano, Switzerland.; Manchester Cancer Research Centre, Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2021 Apr; Vol. 7, pp. 559-571.
Autor:
Scheinberg M; a Rheumatology Section - Orthopedics Department , Hospital Israelita Albert Einstein , São Paulo , Brazil., Pineda C; b Division of Musculoskeletal and Rheumatic Diseases , Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra , Mexico City , Mexico., Castañeda-Hernández G; c Department of Pharmacology , Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional , Mexico City , Mexico., Zarbá JJ; d Oncology Department , Hospital Centro de Salud Zenón J. Santillán , San Miguel de Tucumán , Argentina.; e Facultad de Medicina, Universidad Nacional de Tucumán , San Miguel de Tucumán , Argentina., Damião A; f Department of Gastroenterology , University of São Paulo Medical School , São Paulo , Brazil., Arantes LH Jr; g Pfizer Inc , New York , NY , USA., Jacobs I; g Pfizer Inc , New York , NY , USA.
Publikováno v:
MAbs [MAbs] 2018 Aug/Sep; Vol. 10 (6), pp. 827-842. Date of Electronic Publication: 2018 Aug 29.